Walgreens (WBA) has struggled ever since it entered the Dow in June 2018, falling over 35% since its late-2018 highs and becoming the Average’s worst-performing member in 2019. At its current levels though, the stock looks too cheap to be ignored. However, core questions regarding its future growth remain unanswered, and its path forward looks risky and uncertain. Thus, investors in Walgreens should treat it as a value and dividend stock with limited upside potential.
Struggling to Deliver Consistent Profits
Walgreens’ recent declines has been driven by repeated poor financial performance. In the